Concepedia

Publication | Open Access

Type I Interferons in the Treatment of Pancreatic Cancer

79

Citations

43

References

2007

Year

Abstract

The antitumor activity of IFN-beta is more potent than IFN-alpha in pancreatic cancer cell lines through the induction of apoptosis. Further studies should investigate in vivo whether the intensity and distribution of IFNAR-1 and IFNAR-2c may predict the response to therapy with IFN-alpha and IFN-beta in pancreatic cancer.

References

YearCitations

Page 1